Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal

被引:70
作者
Clayson, ET
Shrestha, MP
Vaughn, DW
Snitbhan, R
Shrestha, KB
Longer, CF
Innis, BL
机构
[1] ARMED FORCES RES INST MED SCI,DEPT VIROL,BANGKOK 10400,THAILAND
[2] INFECT DIS HOSP,KATMANDU,NEPAL
[3] BIRENDRA ARMY HOSP,KATMANDU,NEPAL
[4] WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DEPT VIRUS DIS,WASHINGTON,DC 20307
关键词
D O I
10.1086/517296
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine hepatitis E virus (HEV) infection and disease rates in the Kathmandu Valley of Nepal, serum was collected from 757 healthy Nepalese (ages 12-48 years) during March and September 1992 and September 1993. At each visit, reports of interval illness were obtained. Sera were examined for IgG to HEV, using a commercially available kit. Seroconversion was used as a marker for HEV infection, and an episode of hepatitis E was defined as a history of jaundice with seroconversion, Seroprevalence ranged from 16% to 31% and increased with age, whereas both infection and disease rates decreased with age. Infection and disease rates were as high as 99/1000 and 45/1000 person-years, respectively. These results highlight the importance of sporadic hepatitis E as a public health problem among adolescents and young adults in this region.
引用
收藏
页码:763 / 766
页数:4
相关论文
共 11 条
  • [1] AGE-SPECIFIC PREVALENCE OF ANTIBODIES TO HEPATITIS-A AND HEPATITIS-E VIRUSES IN PUNE, INDIA, 1982 AND 1992
    ARANKALLE, VA
    TSAREV, SA
    CHADHA, MS
    ALLING, DW
    EMERSON, SU
    BANERJEE, K
    PURCELL, RH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) : 447 - 450
  • [2] VIREMIA, FECAL SHEDDING, AND IGM AND IGG RESPONSES IN PATIENTS WITH HEPATITIS-E
    CLAYSON, ET
    MYINT, KSA
    SNITBHAN, R
    VAUGHN, DW
    INNIS, BL
    CHAN, L
    CHEUNG, P
    SHRESTHA, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04) : 927 - 933
  • [3] SOLID-PHASE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HEPATITIS-E VIRUS IGG AND IGM ANTIBODIES UTILIZING RECOMBINANT ANTIGENS AND SYNTHETIC PEPTIDES
    DAWSON, GJ
    CHAU, KH
    CABAL, CM
    YARBOUGH, PO
    REYES, GR
    MUSHAHWAR, IK
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1992, 38 (01) : 175 - 186
  • [4] ENZYME-IMMUNOASSAY FOR THE DETECTION OF ANTIBODY TO HEPATITIS-E VIRUS-BASED ON SYNTHETIC PEPTIDES
    FAVOROV, MO
    KHUDYAKOV, YE
    FIELDS, HA
    KHUDYAKOVA, NS
    PADHYE, N
    ALTER, MJ
    MAST, E
    POLISH, L
    YASHINA, TL
    YARASHEVA, DM
    ONISCHENKO, GG
    MARGOLIS, HS
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1994, 46 (02) : 237 - 250
  • [5] VERTICAL TRANSMISSION OF HEPATITIS-E VIRUS
    KHUROO, MS
    KAMILI, S
    JAMEEL, S
    [J]. LANCET, 1995, 345 (8956): : 1025 - 1026
  • [6] LONGER CF, 1994, VIRAL HEPATITIS LIVE, P409
  • [7] EPIDEMIOLOGY OF VIRAL-HEPATITIS - AN OVERVIEW
    MAST, EE
    ALTER, MJ
    [J]. SEMINARS IN VIROLOGY, 1993, 4 (05): : 273 - 283
  • [8] SEROEPIDEMIOLOGY OF HEPATITIS-E IN SELECTED AUSTRALIAN POPULATIONS
    MOAVEN, L
    VANASTEN, M
    CROFTS, N
    LOCARNINI, SA
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (03) : 326 - 330
  • [9] DETERMINATION OF HEPATITIS-E VIRUS SEROPREVALENCE BY USING RECOMBINANT FUSION PROTEINS AND SYNTHETIC PEPTIDES
    PAUL, DA
    KNIGGE, MF
    RITTER, A
    GUTIERREZ, R
    PILOTMATIAS, T
    CHAU, KH
    DAWSON, GJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) : 801 - 806
  • [10] Xia X, 1991, Zhonghua Liu Xing Bing Xue Za Zhi, V12, P257